NUVACO Film-coated tablet Ref.[51229] Active ingredients: Dolutegravir Lamivudine Tenofovir disoproxil

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2022  Publisher: Adcock Ingram Limited, 1 New Road, Erand Gardens, Midrand, 1685 Customer Care: 0860 ADCOCK (232625)

Product name and form

NUVACO, 300 mg, 300 mg, 50 mg, film-coated tablets.

Pharmaceutical Form

Film-coated tablets.

Orange coloured, modified capsule shaped, biconvex film-coated tablets debossed with ‘H’ on one side, and ‘D 17’ on the other side.

Qualitative and quantitative composition

Each NUVACO film-coated tablet contains:

Lamivudine 300 mg.
Tenofovir disoproxil fumarate 300 mg.
Dolutegravir sodium equivalent to dolutegravir 50 mg.

Contains sugar (140,4 mg mannitol per tablet).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Dolutegravir

Dolutegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral Deoxyribonucleic acid (DNA) integration which is essential for the HIV replication cycle.

Lamivudine

Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription.

Tenofovir disoproxil

Tenofovir disoproxil is absorbed and converted to the active substance tenofovir, which is a nucleoside monophosphate analogue. Tenofovir is then converted to the active metabolite, tenofovir diphosphate, an obligate chain terminator, by constitutively expressed cellular enzymes. Tenofovir diphosphate inhibits HIV-1 reverse transcriptase and the HBV polymerase by direct binding competition with the natural deoxyribonucleotide substrate and, after incorporation into DNA, by DNA chain termination.

List of Excipients

Tablet core:

Croscarmellose sodium
Hydroxypropyl cellulose
Magnesium stearate
Mannitol
Microcrystalline cellulose
Povidone
Sodium starch glycolate
Sodium stearyl fumarate

Film coating:

Iron oxide red
Iron oxide yellow
Macrogol/polyethylene glycol
Polyvinyl alcohol
Talc
Titanium dioxide

Pack sizes and marketing

Pack sizes 28, 30, 56, 60, 84, 90, 100, 180 and 750 film-coated tablets: NUVACO tablets are packed in a white opaque high density polyethylene (HDPE) container with a cotton or rayon coil wadding and a desiccant canister containing silica gel. The HDPE container is closed with a white polypropylene, child-resistant cap with heat seal induction liner or pulp liner. Pack size of 30’s is packed in an outer carton.

Not all pack sizes may be marketed.

Marketing authorization holder

Adcock Ingram Limited, 1 New Road, Erand Gardens, Midrand, 1685

Customer Care: 0860 ADCOCK (232625)

Marketing authorization dates and numbers

52/20.2.8/0949

10 October 2018

Drugs

Drug Countries
NUVACO South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.